ALLOGRAFT, A Study to Evaluate the Renal Protective Effects of Losartan (0954-222)(COMPLETED)

NCT00140907 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

367

Enrollment

INDUSTRY

Sponsor class

Conditions

High Blood Pressure

Interventions

DRUG: losartan potassium
DRUG: Comparator: Placebo

Sponsor

Organon and Co